Skip to main content

Rabbit Recombinant Monoclonal MIOX antibody. Carrier free. Suitable for IP, WB and reacts with Human samples.

Be the first to review this product! Submit a review

Images

Western blot - Anti-MIOX antibody [EPR17173] - BSA and Azide free (AB251262), expandable thumbnail
  • Immunoprecipitation - Anti-MIOX antibody [EPR17173] - BSA and Azide free (AB251262), expandable thumbnail

Key facts

Isotype
IgG
Host species
Rabbit
Storage buffer

pH: 7.2 - 7.4
Constituents: PBS

Form
Liquid
Clonality
Monoclonal

Immunogen

  • The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
IPWB
Human
Tested
Tested

Tested
Tested

Species
Human
Dilution info
-
Notes

-

Tested
Tested

Species
Human
Dilution info
-
Notes

-

Alternative names

Recommended products

Rabbit Recombinant Monoclonal MIOX antibody. Carrier free. Suitable for IP, WB and reacts with Human samples.

Key facts

Isotype
IgG
Form
Liquid
Clonality
Monoclonal
Immunogen
  • The exact immunogen used to generate this antibody is proprietary information.
Carrier free
Yes
Clone number
EPR17173
Concentration
Loading...

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Notes

ab251262 is the carrier-free version of Anti-MIOX antibody [EPR17173] ab198997.

Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.

This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

The protein MIOX also known as myo-inositol oxygenase plays an important role in the conversion of myo-inositol into D-glucuronic acid. This metabolic enzyme has a mass of about 33 kDa. It is expressed mainly in the kidney particularly in the proximal tubules. MIOX functions as a monomer and contains a non-heme iron at its active site which is essential for its enzymatic activity.

Biological function summary

MIOX is involved in myo-inositol metabolism an important process for maintaining cellular osmolyte balance and signaling. It does not form part of a larger protein complex. Myo-inositol metabolism impacts various cellular functions including phosphoinositide synthesis which is important for cellular signaling pathways. MIOX by controlling myo-inositol levels therefore influences these cellular processes that are critical for kidney function.

Pathways

MIOX is a part of the inositol phosphate metabolism pathway. This pathway is critical for glucose and lipid metabolism affecting energy balance and cellular homeostasis. Additionally MIOX interacts with proteins involved in glucose metabolism such as enzymes in the glycolytic pathway highlighting its role in energy production and regulation. These interactions showcase MIOX's integration in broader metabolic networks.

Associated diseases and disorders

Abnormal MIOX activity links to conditions such as diabetic nephropathy and kidney injury. MIOX overexpression has been observed in diabetic nephropathy where it might contribute to oxidative stress and kidney damage. Additionally altered MIOX activity associates with proteins like SOD1 which is implicated in oxidative stress responses. Understanding MIOX's involvement offers potential therapeutic insights for managing related renal disorders.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Western blot - Anti-MIOX antibody [EPR17173] - BSA and Azide free (ab251262), expandable thumbnail

    Western blot - Anti-MIOX antibody [EPR17173] - BSA and Azide free (ab251262)

    This data was developed using Anti-MIOX antibody [EPR17173] ab198997, the same antibody clone in a different buffer formulation.

    Blocking and dilution buffer: 5% NFDM/TBST.

    MIOX is specifically expressed in the kidney. Lane 2, Human fetal heart, represents a negative control.

    All lanes: Western blot - Anti-MIOX antibody [EPR17173] (Anti-MIOX antibody [EPR17173] ab198997) at 1/2000 dilution

    Lane 1: Human fetal kidney lysate at 10 µg

    Lane 2: Human fetal heart lysate at 10 µg

    Secondary

    All lanes: Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

    Predicted band size: 33 kDa

    Observed band size: 33 kDa

    Exposure time: 10s

  • Immunoprecipitation - Anti-MIOX antibody [EPR17173] - BSA and Azide free (ab251262), expandable thumbnail

    Immunoprecipitation - Anti-MIOX antibody [EPR17173] - BSA and Azide free (ab251262)

    This data was developed using Anti-MIOX antibody [EPR17173] ab198997, the same antibody clone in a different buffer formulation.

    MIOX was immunoprecipitated from 1mg of Human fetal kidney whole cell extract with Anti-MIOX antibody [EPR17173] ab198997 at 1/150 dilution. Western blot was performed using Anti-MIOX antibody [EPR17173] ab198997 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.

    Lane 1: Human fetal kidney whole cell extract 10μg (Input).

    Lane 2: Anti-MIOX antibody [EPR17173] ab198997 IP in Human fetal kidney whole cell extract.

    Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of Anti-MIOX antibody [EPR17173] ab198997 in Human fetal kidney whole cell extract.

    Blocking and dilution buffer: 5% NFDM/TBST.

    All lanes: Immunoprecipitation - Anti-MIOX antibody [EPR17173] (Anti-MIOX antibody [EPR17173] ab198997)

    Predicted band size: 33 kDa

    Observed band size: 33 kDa

    Exposure time: 5s

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com